Alonzo Weems

SVP, ERM & CECO, Eli Lilly and Company.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 12, 2024Granted 951 shares at $737.26 of Eli Lilly and Company²
Sep 12, 2023Gift 760 shares of Eli Lilly and Company³
Sep 12, 2023Sold 1,148 shares at $590.98 of Eli Lilly and Company³
Mar 10, 2023Sold 1,000 shares at $318.85 of Eli Lilly and Company⁴
Mar 1, 2023Shares withheld for tax 793 shares at $311.22 of Eli Lilly and Company⁵
Mar 1, 2023Exercised options 1,779 shares of Eli Lilly and Company⁵
Feb 10, 2023Granted 2,422 shares at $345.12 of Eli Lilly and Company⁶
Oct 10, 2022Gift 450 shares of Eli Lilly and Company⁷
Oct 10, 2022Sold 656 shares at $326.23 of Eli Lilly and Company⁷
Aug 10, 2022Gift 530 shares of Eli Lilly and Company⁸
Aug 10, 2022Sold 656 shares at $304.50 of Eli Lilly and Company⁸
Feb 9, 2022Granted 3,731 shares at $243.27 of Eli Lilly and Company⁹

Date	Stock	Trade	Value	Return since	Vs S&P since	Vs S&P, 1 year
Sep 12, 2023	LLY	Sale	$678.4K	+108.8%	−35.8%	−29.3%
Mar 10, 2023	LLY	Sale	$318.9K	+297.3%	−197.3%	−100.6%
Oct 10, 2022	LLY	Sale	$214.0K	+286.4%	−172.1%	−58.2%
Aug 10, 2022	LLY	Sale	$199.8K	+310.9%	−227.1%	−65.0%

Returns are price-only (no dividends), measured from the trade date.

The numbers on this page point here. Each one links to the record it came from.